• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2007 NIHR Horizon Scanning Centre (NIHR HSC) Azacitidine for myelodysplastic syndrome: horizon scanning technology briefing
2007 NIHR Horizon Scanning Centre (NIHR HSC) Homoharringtonine (Ceflatonin) for chronic myeloid leukaemia
2007 NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for chronic lymphocytic leukaemia
2007 NIHR Horizon Scanning Centre (NIHR HSC) Generex Oral-lyn (buccal insulin) for diabetes mellitus
2007 NIHR Horizon Scanning Centre (NIHR HSC) Pregabalin (Lyrica) for fibromyalgia
2007 NIHR Horizon Scanning Centre (NIHR HSC) Milnacipran for fibromyalgia
2007 NIHR Horizon Scanning Centre (NIHR HSC) Magnetic Source Imaging (MSI) for the characterisation and localisation of epileptic abnormalities and brain tumours
2007 NIHR Horizon Scanning Centre (NIHR HSC) SpeechEasy altered auditory feedback device for stammer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2007 NIHR Horizon Scanning Centre (NIHR HSC) CNTO-1275 (Ustekinumab) for moderate to severe psoriasis
2007 NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib (Sutent) for advanced and/or metastatic breast cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with bevacizumab for advanced or metastatic non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for recurrent and/or unresectable squamous cell carcinoma of the head and neck
2007 NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for Li-Fraumeni syndrome associated cancers
2007 NIHR Horizon Scanning Centre (NIHR HSC) Arsenic trioxide (Trisenox) for acute promyelocytic leukaemia - first line therapy
2007 NIHR Horizon Scanning Centre (NIHR HSC) Plerixafor (Mozobil) for stem-cell mobilisation in multiple myeloma
2007 NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (Mabthera) for non-Hodgkin’s lymphoma – first line maintenance therapy
2007 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for relapsed ovarian cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima, -6474, AZD-6474, ZD6474) for medullary thyroid cancer – locally advanced or metastatic
2007 NIHR Horizon Scanning Centre (NIHR HSC) Dronedarone (Multaq) for atrial fibrillation and atrial flutter
2007 NIHR Horizon Scanning Centre (NIHR HSC) Rimonabant (Acomplia) for type 2 diabetes
2007 NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (CNTO-148) for rheumatoid arthritis
2007 NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (CNTO-148) for psoriatic arthritis
2007 NIHR Horizon Scanning Centre (NIHR HSC) Ampligen for chronic fatigue syndrome
2007 NIHR Horizon Scanning Centre (NIHR HSC) Tarenflurbil (Flurizan, R-Flurbiprofen) for Alzheimer’s disease – mild
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Description of cancer screening in Spain. DESCRIC Project
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Development of process and outcomes indicators, and assessment of oncology health care practice
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Description of the current status of the prenatal screening of the most frequent fetal chromosomal diseases -especially Down's Syndrome- in Spain, and proposals for improvement of everyday clinical practice
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Development of the methodology and pilot implementation of prosthetic implant registers in the National Health system
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [8th Symposium Health Technology Assessment - Decision-making in medicine, 2007, October 18 - 19, Cologne]
2007 Agency for Health Technology Assessment in Poland (AHTAPol) Use of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension in Poland. Budget impact analysis.
2007 Agency for Health Technology Assessment in Poland (AHTAPol) Treatment of pulmonary arterial hypertension in Poland - current practice. Survey results
2007 HAYES, Inc. 3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for multiple sclerosis
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Drug-eluting stents for the treatment of in-stent restenosis
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Botulinum toxin in obstetric paralysis
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Endopyelotomy with stent in the ureteropelvic joint obstruction
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Angioplasty with stenting in recurrent stroke
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Idursulfase for the treatment of Hunter syndrome
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Deep brain stimulation for patients with poststroke sequelae
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Enzyme replacement therapy in mucopolysaccharidosis type I
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of intervertebral disc prostheses for spine diseases
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Etanercept in the treatment of erythema nodosum
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Total ankle arthroplasty
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Enzyme replacement therapy in Fabry disease
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Exenatide in patients with type 2 diabetes
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Enzyme replacement therapy in Gaucher disease
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Kyphoplasty in the treatment of vertebral fractures caused by osteoporosis
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Motor cortex stimulation in the treatment of central and neuropathic pain
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Antidepressants for the management of post-stroke executive dysfunction
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Tigecycline: usefulness of its clinical application
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Effectiveness of dasatinib in chronic myeloid leukemia
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Gait analysis in patients with gait disorders of neurological origin
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Palivizumab to prevent respiratory syncytial virus infections of the lower tract
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of the European Appropriateness Evaluation Protocol (AEP)
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Insulin detemir for the management of patients with diabetes
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Immune tolerance induction in hemophilia patients
2007 Institute for Clinical Effectiveness and Health Policy (IECS) C-reactive protein as cardiovascular disease prognostic marker
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Role of anti cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Effectiveness of third ventricle neuroendoscopy in hydrocephalus
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Cognitive rehabilitation: main indications
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Elective endovascular repair for aortic abdominal aneurysm
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Green light laser urological indications
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of SPECT in epilepsy
2007 Institute for Clinical Effectiveness and Health Policy (IECS) Evaluation of home care utility: pneumonia, cerebrovascular disease, urinary tract infections and postsurgical infections
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Development of tools to assess the results of technologies applied to the rehabilitation process. Study based on two specific models: spinal lesions and acquired brain damage
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Sunitinib in metastatic renal-cell cancer: efficacy and safety
2007 HAYES, Inc. AGILE patency system (Given Imaging Ltd.) for verification of gastrointestinal patency prior to capsule endoscopy
2007 HAYES, Inc. Alpha-1 Antitrypsin (AAT) replacement therapy for AAT deficiency lung emphysema
2007 HAYES, Inc. Arthroscopic microdiscectomy for lumbar disc herniation
2007 HAYES, Inc. Autologous platelet-rich plasma to aid bone fusion following ankle surgery
2007 HAYES, Inc. Autologous stem cell transplantation for acute myocardial infarction
2007 HAYES, Inc. Avastin (bevacizumab) (Genentech Inc.) for metastatic breast cancer
2007 HAYES, Inc. BARRX's HALO360 coagulation system (BARRX Medical Inc.) for Barrett's esophagus
2007 HAYES, Inc. Blood volume analysis using the BVA-100 blood volume analyzer (Daxor Corp.) for management of patients with chronic heart failure
2007 HAYES, Inc. Cancer antigen 15-3 (CA 15-3) for breast cancer prognosis
2007 HAYES, Inc. Cancer antigen 27.29 (CA 27.29) for diagnosis, staging, and treatment monitoring of breast cancer
2007 HAYES, Inc. CellSearch circulating tumor cell kit (Veridex LLC) for monitoring breast cancer
2007 HAYES, Inc. Cold therapy device (Cryo/Cuff; Aircast Inc.) for treatment of musculoskeletal and postoperative orthopedic trauma
2007 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Pedometer and accelerometer in assessing physical activity among children and adolescents
2007 Institute of Health Economics (IHE) Evidence of benefit from telemental health applications: a systematic review
2007 Institute of Health Economics (IHE) The use of videoconferencing for mental health services in Canada and Finland
2007 HAYES, Inc. Dermoscopy for detection of melanoma
2007 HAYES, Inc. DISC nucleoplasty (ArthroCare Perc-D SpineWand) for percutaneous disc decompression
2007 HAYES, Inc. Dynesys dynamic stabilization system (Zimmer Inc.) for degenerative spondylolisthesis
2007 HAYES, Inc. Electrical stimulation of the occipital nerve for the treatment of occipital neuralgia
2007 HAYES, Inc. Endoscopic strip craniectomy with cranial helmet molding for primary craniosynostosis
2007 HAYES, Inc. Erythropoiesis-stimulating agents (ESAs) for interferon/ribavirin-induced anemia in HIV-negative patients with hepatitis C
2007 HAYES, Inc. ExAblate 2000 system (InSightec Ltd.) for ablation of uterine fibroids
2007 HAYES, Inc. Extracorporeal photopheresis for the treatment of chronic graft rejection after lung transplantation
2007 HAYES, Inc. Gastric electrical stimulation with an implantable gastric stimulator (IGS) for the treatment of obesity
2007 HAYES, Inc. Histamine desensitization therapy for prophylaxis against intractable migraine or chronic cluster headaches
2007 HAYES, Inc. Humira (adalimumab) (Abbott Laboratories) for Crohn's Disease
2007 HAYES, Inc. Hyperbaric oxygen (HBO) for treatment of cerebral palsy
2007 HAYES, Inc. Injection of Radiesse (BioForm Medical Inc.) for the treatment of glottic insufficiency including unilateral vocal cord paralysis (UVCP)